New insights into antimetastatic and antiangiogenic effects of cannabinoids

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Cannabinoids exhibit antitumorigenic properties, with a focus on antimetastatic and antiangiogenic effects.
• Cannabinoids modulate cancer cell gene expression and secretomic profiles, reducing aggressiveness and invasiveness.
• Cannabinoids suppress tumor angiogenesis by inhibiting endothelial cell proliferation, migration, and tube formation.

Purpose of the Study:

• To review the antitumorigenic mechanisms of cannabinoids, emphasizing their antimetastatic and antiangiogenic actions.
• To explore the role of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mediating cannabinoid effects.
• To discuss potential interactions between cannabinoids, chemotherapy, and tumor-immune surveillance.

Main Methods:

• Review of existing scientific literature on cannabinoid mechanisms in cancer.
• Analysis of studies investigating gene expression and secretomic changes in cancer cells treated with cannabinoids.
• Examination of research on the direct effects of cannabinoids on endothelial cell angiogenic capacities.

Main Results:

• Cannabinoids reduce cancer cell invasiveness and metastasis by altering gene expression and secretomic profiles.
• Cannabinoids inhibit angiogenesis through mechanisms including the upregulation of TIMP-1.
• Cannabinoids directly suppress endothelial cell proliferation, migration, and tube formation, contributing to antiangiogenesis.

Conclusions:

• Cannabinoids possess significant antimetastatic and antiangiogenic properties.
• Cannabinoids, particularly through TIMP-1 modulation, offer a multifaceted approach to cancer treatment.
• Cannabinoids represent a potential complementary therapeutic strategy in cancer pharmacotherapy, with possible synergistic effects with chemotherapy and immune modulation.